Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Neutralizing Antibody
73%
Glycan
73%
Spike
64%
Neutralization
54%
Human immunodeficiency virus
46%
Human Immunodeficiency Virus 1
44%
COVID-19
41%
Epitope
35%
Glycoprotein
33%
Antibody Response
33%
Monoclonal Antibody
29%
Virus
27%
T Cell
16%
B Cell
16%
Glycosylation
16%
Immune Response
14%
Breakthrough Infection
13%
Receptor Binding
12%
Amino Terminal Sequence
12%
Humoral Immunity
11%
Omicron Coronavirus Variant
10%
Seroconversion
9%
Memory B Cell
9%
HIV Vaccine
9%
Human Immunodeficiency Virus Antibody
8%
Immunogenicity
7%
CD4
7%
Interferon Type I
7%
Dynamics
6%
Antibody Titer
6%
Cell Line
6%
Lineages
6%
Virion
6%
Antigenicity
6%
Titer
5%
Infectious Agent
5%
Face
5%
Glycopeptide
5%
Pulse Rate
5%
Nipah virus
5%
Hantavirus
5%
Metabolite
5%
Capsid
5%
Heme
5%
Envelope Glycoprotein GP120
5%
Gp41
5%
Biochemistry, Genetics and Molecular Biology
SARS Coronavirus
41%
Polysaccharides
41%
Human immunodeficiency virus
30%
Human Immunodeficiency Virus 1
29%
Neutralizing Antibody
27%
Mannose
19%
Spike
19%
Glycoprotein
16%
B Cell
10%
T Cell
10%
Antibody Response
9%
Glycosylation
9%
Glycopeptide
6%
Seroconversion
6%
Immune Response
6%
Mass Spectrometry
5%
Pulse Rate
5%
N-Linked Glycosylation
5%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
52%
COVID-19
42%
Infection
23%
Diseases
11%
Humoral Immunity
9%
COVID-19 Vaccine
8%
Neutralizing Antibody
8%
T-Cell Response
7%
Hematologic Malignancy
6%
Antibody Response
5%
T Cell
5%
Neutralization
5%
Memory B Cell
5%
Medicine
5%
Virus
5%
COVID-19 Vaccination
5%